United States Neuromodulation Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     United States 
Neuromodulation Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a te s t  r e p o r t  b y  I M A R C  Gr o up ,  t i t l e d  " U n i te d  S t a t e s  
N eu r o m o d u l a t i o n  M ar k e t :  In d u s t ry  T r e n d s ,  S h ar e ,  S i ze ,  G r o wt h ,  Op p o r tu n i t y  an d  
F o r e c a s t  2 02 4 - 2 0 32 , "  t h e  U n i t e d  S t a t es  n eu r o mo d u l a t i on  ma r k e t  s i z e  i s  p r o j e c t e d  t o  
ex h i b i t  a  g r o w th  r a t e  ( C A GR )  o f  1 1 . 50 %  d u r i n g  2 02 4 - 2 0 32 .
Report T he  U n i t e d  S t a t es  n e u r o mo d u l a t i o n  m a r k e t  i s  e x p e r i e nc i n g  s i g n i f i ca n t  g r o w t h ,  p r i m a r i l y  d r i v e n  by  t ec h n o l o g i c a l  ad v a n c em e n ts  i n  n e u r om o d u l a t i o n  d e v i c e s .  I n  ad d i t i o n  t o  t h i s ,  
t he  i n c r e a s i n g  p r ev a l e nc e  o f  c h r o n i c  c o nd i t i o n s  s u ch  a s  ch r o n i c  p a i n ,  ep i l e p s y ,  a nd  
Highlight and P ar k i n s on ' s  d i s e a s e  i s  f u r t h e r  p r o p e l l i ng  t h e  m a r k e t  g r ow t h .  
T he s e  co n d i t i o ns  a r e  o f t e n  r e s i s ta n t  t o  c o n v e n t i o n a l  m e d i ca l  t r e a t m en t s ,  m a k i ng  
ne u r o m od u l a t i o n  a  v i t a l  a l t e r n a t i v e  fo r  e f f e c t i v e  m an a g e me n t .  B e s i d es  t h i s ,  t h e  g r o w i ng  
Description aw a r e n e ss  o f  t h e  p o t e n t i a l  be n e f i t s  o f  n e u ro m o d u l a t i o n  t h e r a p i e s ,  i n c l u d i ng  s p i n a l  c o rd  
s t i mu l a t i o n  ( S C S )  a n d  d ee p  b r a i n  s t i m u l a t i o n  ( D B S ) ,  w h i c h  o f f e r  s i g n i f i c an t  r e l i e f  f o r  
pa t i e n t s  w i t h  ch r o n i c  p a i n  a nd  m o v em e n t  d i s o r d e r s  i s  a c t i ng  a s  a n o t h e r  s i gn i f i c a n t  
f ac t o r  i n  t h e  m a r k e t  g r ow t h .
R eq u e s t  f o r  a  P D F  sa m p l e  o f  t h i s  re p o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / u n i te d - s t a t e s -n e u r o mo d u l a t i o n - ma r k e t / r e q u e s t s a mp l e
Report Description
Uni ted Sta tes  Neuromodula t ion Market  Trends :
Fur thermore ,  the  r i s ing  ge r ia t r i c  popu la t ion  in  the  U .S . ,  wh ich  is  more  suscep t ib le  to  neuro log ica l  d i so rders ,  i s  
augment ing  the  Un i ted  S ta tes  neuromodu la t ion  marke t .  Th is  demograph ic  sh i f t  i s  lead ing  to  a  h igher  demand fo r  
advanced  and  min ima l ly  invas ive  t rea tments ,  p rope l l ing  the  neuromodu la t ion  marke t  f o rward .  Add i t iona l l y ,  the  
inc reas ing  inves tment  i n  R&D ac t i v i t ies  by  key  p layers  in  the  neuromodu la t ion  space  wh ich  leads  to  the  
in t roduc t ion  o f  innova t ive  and  more  e f fec t ive  p roduc ts  i s  c rea t ing  a  pos i t i ve  ou t look  fo r  the  marke t .  
The  g row ing  unders tand ing  o f  the  human neuro log ica l  sys tem and  how i t  m igh t  be  con t ro l led  fo r  t he rapeu t i c  
reasons  opens  up  new pa ths  fo r  t he rapy.  Bes ides  th i s ,  t he  imp lementa t ion  o f  suppor t i ve  government  po l i c ies  and  
the  ava i lab i l i t y  o f  favo rab le  re imbursement  scena r ios ,  a re  fu r the r  acce le ra t ing  the  g rowth  o f  the  neu romodu la t ion  
marke t  in  the  Un i ted  S ta tes .  Moreover ,  the  ongo ing  advancements  and  the  inc reas ing  adop t ion  o f  nove l  
the rap ies ,  a re  an t i c ipa ted  to  boos t  the  Un i ted  S ta tes  neu romodu la t ion  marke t  in  the  coming  years .
View Repor t  TOC,  F igures  and  Tables :  h t tps: / /www. imarcgroup.com/uni ted -s ta tes-neuromodula t ion-marke t
Technology Insights:
• Internal  Neuromodulat ion
o Spinal  Cord St imulat ion (SCS)
o Deep Brain St imulat ion (DBS)
o Vagus Nerve St imulat ion (VNS)
o Sacral  Nerve St imulat ion (SNS)
o Gastr ic E lectr ical  St imulat ion (GES)
Report • External  Neuromodulat ion
Segmentation o Transcutaneous Electr ical  Nerve 
St imulat ion (TENS)
o Transcranial  Magnetic St imulat ion (TMS)
o Others
 
Biomaterial Insights:
• Metall ic  Biomater ials
• Polymeric Biomater ials
• Ceramic Biomaterials
Application Insights:
• Parkinson's Disease
• Epi lepsy
• Depression
Report • Dystonia
• Pain Management
Segmentation • Others
Regional Insights:
• Northeast 
• Midwest
• South
• West
How has the United States neuromodulation market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the United States 
neuromodulation market?
What is the breakup of the United States neuromodulation 
market on the basis of technology?
Key 
What is the breakup of the United States neuromodulation 
Questions market on the basis of biomaterial?
Answered in What is the breakup of the United States neuromodulation market on the basis of application?
the Report What are the various stages in the value chain of the United 
States neuromodulation market?
What are the key driving factors and challenges in the United 
States neuromodulation?
What is the structure of the United States neuromodulation 
market and who are the key players?
What is the degree of competition in the United States 
neuromodulation market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4      U n i t e d  S t a t e s  N e u r o m o d u l a t i o n  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    U n i t e d  S t a t e s  N e u r o m o d u l a t i o n  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    U n i t e d  S t a t e s  N e u r o m o d u l a t i o n  M a r k e t  -  B r e a k u p  b y  T e c h n o l o g y
    6 . 1     I n t e r n a l  N e u r o m o d u l a t i o n
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
           6 . 1 . 3 . 1  S p i n a l  C o r d  S t i m u l a t i o n  ( S C S )
           6 . 1 . 3 . 2  D e e p  B r a i n  S t i m u l a t i o n  ( D B S )
           6 . 1 . 3 . 3  V a g u s  N e r v e  S t i m u l a t i o n  ( V N S )
           6 . 1 . 3 . 4  S a c r a l  N e r v e  S t i m u l a t i o n  ( S N S )
           6 . 1 . 3 . 5  G a s t r i c  E l e c t r i c a l  S t i m u l a t i o n  ( G E S )
        6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
    6 . 2     E x t e r n a l  N e u r o m o d u l a t i o n
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  S e g m e n t a t i o n
           6 . 2 . 3 . 1  T r a n s c u t a n e o u s  E l e c t r i c a l  N e r v e  S t i m u l a t i o n  ( T E N S )
           6 . 2 . 3 . 2  T r a n s c r a n i a l  M a g n e t i c  S t i m u l a t i o n  ( T M S )
           6 . 2 . 3 . 3  O t h e r s
        6 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7    U n i t e d  S t a t e s  N e u r o m o d u l a t i o n  M a r k e t  -  B r e a k u p  b y  
B i o m a t e r i a l
Table of     7 . 1     M e t a l l i c  B i o m a t e r i a l s        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
Contents     7 . 2     P o l y m e r i c  B i o m a t e r i a l s
        7 . 2 . 1  O v e r v i e w
        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 3     C e r a m i c  B i o m a t e r i a l s
        7 . 3 . 1  O v e r v i e w
        7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
8    U n i t e d  S t a t e s  N e u r o m o d u l a t i o n  M a r k e t  -  B r e a k u p  b y  
A p p l i c a t i o n
    8 . 1     P a r k i n s o n ' s  D i s e a s e
        8 . 1 . 1  O v e r v i e w
        8 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / u n i t e d - s t a t e s - n e u ro m o d u la t i o n - m a
r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]